Jean-Jacques Kiladjian/LinkedIn
Nov 24, 2025, 10:25
Jean Jacques Kiladjian Visits INSERM-supervised CIC 1408 Investigation Center
Jean Jacques Kiladjian, Head of Clinical Research Department of Inserm, shared on LinkedIn:
”A busy day visiting the INSERM-supervised CIC 1408 clinical investigation center in Saint-Etienne during its evaluation by HCERES, showcasing its dynamism and impressive scientific output in clinical pharmacology and public health, with a strong focus on vascular/hemostasis, immunomonitoring, inflammatory diseases (IBD and systemic), vaccinology, population health, paramedical research, and mental health.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease